Well-Being and Suicidality Among Transgender Youth After Gender-Affirming Hormones

作者：Luke R. Allen, Laurel B. Watson, Anna Egan, Christine N. Moser · 发表于：Clinical Practice in Pediatric Psychology · 年份：2019 · DOI：10.1037/cpp0000288 · 被引用次数：189 · 研究领域：LGBTQ Health, Identity, and Policy、Reproductive Health and Technologies、Sexuality, Behavior, and Technology

Objective: This study is a longitudinal evaluation of the effectiveness of gender-affirming hormones for improving psychological well-being and decreasing suicidality among transgender youth referred to a transgender health specialty clinic at a large Midwest children’s hospital. Method: Forty-seven youth (13.73–19.04 years; M = 16.59, SD = 1.19) who received gender-affirming hormones were assessed at least 2 times: before the start of treatment and at least 3 months after treatment. Results: After gender-affirming hormones, a significant increase in levels of general well-being and a significant decrease in levels of suicidality were observed. Conclusion: These findings suggest that gender-affirming hormones are a valuable medical intervention with promising psychosocial outcomes for transgender youth. Implications for Impact Statement This study suggests that gender-affirming hormones are a helpful medical intervention for transgender youth. Gender-affirming hormones were found to be associated with decreases in suicidality and improvements in general well-being.